The expression ratio of BCL2/miR-497 has a close relationship with disease development in patients with CRC, miR-497 is in relation with clinical pathological characteristics and CRC prognosis, and the expression ratio of BCL2/miR-497 is correlated with poor CRC prognosis and short survival. The gene discussed is BCL2; the disease is colorectal carcinoma.